Review

PROCTER & GAMBLE HYGIENE AND HEALTH CARE LTD.

Ticker : 500459
FV : Rs 10
52-Week H/L : Rs 15,147/9,990.05

We recommended Procter & Gamble Hygiene and Healthcare Limited in volume no. 37, issue no. 47 (dated September 13, 2021) when the scrip was trading at Rs 14,130.30. On a standalone quarterly front, the company recorded an increase of 4.84 per cent in the net sales and operating income, which stood at Rs 1,058.30 crore for Q2FY22 as compared to the net sales and operating income of Rs 1,009.45 crore reported for Q2FY21. The operating profit dipped, registering an 11.71 per cent decline at Rs 307.12 crore in Q2FY22 as compared to the operating profit of Rs 347.86 crore recorded in Q2FY21. The company reported a net profit of Rs 218.29 crore in Q2FY22 as against the net profit of Rs 253.86 crore recorded in Q2FY21, contracting by 14.01 per cent. The industry is currently facing commodity inflation but the company continues to remain focussed on its strategy of driving superiority, improving productivity, leading constructive disruption, and strengthening our organisation & culture. Hence, we recommend HOLD.